Awareness and best practices in using ketogenic therapy to treat serious mental illness: a modified Delphi consensus
This consensus provides expert-informed guidance to support the use of KMT in adults with major depressive disorder, bipolar disorder, and schizophrenia.
Authors
- Beth Zupec‐Kania
- Lori Calabrese (ORCID: https://orcid.org/0000-0003-2808-5790)
- Iain H. Campbell (ORCID: https://orcid.org/0000-0001-8756-1326)
- Nicole Laurent (ORCID: https://orcid.org/0009-0005-1153-0095)
- Georgia Ede (ORCID: https://orcid.org/0000-0002-5679-938X)
- Shebani Sethi
- Chris M. Palmer
- Matthew Bernstein
Institutions
- Harvard University (US)
- McLean Hospital (US)
- Royal Edinburgh Hospital (GB)
- Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences (RU)
- International Union for Circumpolar Health (US)
- Renewable Energy Systems (United States) (US)
- Electronics Development Corporation (United States) (US)
- Vital Therapies (United States) (US)
- Stanford University (US)
Publication Details
- Journal
- Frontiers in Nutrition
- Published
- 2026-02-24
- DOI
- https://doi.org/10.3389/fnut.2026.1749406
- Citations
- 1
- Primary Topic
- Diet and metabolism studies
- Type
- article
- Field-Weighted Citation Impact
- 32.84
Funders
- Wellcome Trust
- UK Research and Innovation
- Glut1 Deficiency Foundation
- Medical Research Council